Skip to content
Head to head

GE HealthCare Technologies vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: GEHC · ABT

Updated 3 minutes ago

1-year performance, rebased to 100

GEHC +14.3%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield.
GEHCABT
Snapshot
Sector--Medical Devices
Last price80.64103.00
Change today-1.53%-0.84%
1-year return+8.0%-15.4%
Market cap$36.46B$178.39B
52-week range58.68 – 89.5980.89 – 126.70
Valuation
P/E (TTM)17.0538.29
P/E percentile, own 5-yr range39th99th
P/B3.143.50
Dividend yield0.17%2.41%
Profitability & growth
EPS (TTM)4.553.72
Net profit (TTM)$2.06B$6.44B
Revenue (TTM)$21.64B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+7.2%+14.5%
Gross margin39.9%56.9%
Operating margin13.3%13.8%
Net margin10.0%9.7%
Free cash flow (TTM)$1.89B$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership94.9%81.2%
Insider activity (12mo)30 buy / 17 sell36 buy / 12 sell
Short interest (% of float)4.0%1.1%
Analyst consensus64% buy / 36% hold (14)93% buy / 7% hold (15)
Analyst price target$87 (+8%)$122 (+18%)
StockVane view
StockVane Quant RatingC (55)D (22)
Company
Employees54,000115,000
Founded18921900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.